Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Osteosarcoma
Related studies linked through entity extraction aliases.
Molecular-Guided Therapy for Childhood Cancer
- Status
- COMPLETED
- Phase
- NA
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
- Status
- COMPLETED
- Phase
- N/A
Monocyte Phenotypic and Functional Differences
- Status
- COMPLETED
- Phase
- N/A
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
NAC to Prevent Cisplatin-induced Hearing Loss
- Status
- COMPLETED
- Phase
- PHASE1
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
- Status
- TERMINATED
- Phase
- NA
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
- Status
- COMPLETED
- Phase
- N/A
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Status
- RECRUITING
- Phase
- N/A
Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
- Status
- UNKNOWN
- Phase
- N/A